Neonatal Ventriculitis with Multi Drug Resistant Acinetobactor baumanii: A Case Report and Review of Literature
Veerendra Mehar, Priti Zade, Milind Joshi*, Nitin Rajput and Ganesh Bhatambar
Sri Aurobindo Institute of Medical Sciences, Indore, MP, India
- *Corresponding Author:
- Dr. Milind Joshi
208, Princess Residency Plaza
Opposite Bombay Hospital
Vijaynagar, Indore, M.P, 452010, India
E-mail: [email protected]
Received Date: June 22, 2012; Accepted Date: July 17, 2012; Published Date: July 20, 2012
Citation: Mehar V, Zade P, Joshi M, Rajput N, Bhatambar G (2012) Neonatal Ventriculitis with Multi Drug Resistant Acinetobactor baumanii: A Case Report and Review of Literature. Pediat Therapeut 2:131. doi:10.4172/2161-0665.1000131
Copyright: © 2012 Mehar V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Meningitis due to Multi Drug Resistant Acinetobacter baumannii (MRAB) is a serious emerging problem in pediatric intensive care. Treatment of these patients is challenging and polypeptide antibiotic is an important option but have poor cerebrospinal fluid (CSF) penetration. We describe our experience of a successfully treated neonatal ventriculitis and meningitis due to MRAB with intraventricular polymyxin B.